MedEx, Inc. Announces 4-1 Forward Stock Split

LAS VEGAS, NV--(Marketwire - February 11, 2010) -

Highlighted Links

macreport

MedEx, Inc., a Nevada corporation (PINKSHEETS: MDXX), is pleased to announce a forward stock split of the Company's common stock on the basis of four shares for every one share currently issued and outstanding. The stock split was approved by written consent of the Company's board of directors and a majority of the Company's shareholders effective February 8, 2010. The record date for this stock split shall be the close of business on February 22, 2010. The pay date is February 23, 2010. Holders of fractional shares of the Company's common stock will receive a proportional number of shares. As a result of the stock split, shareholders will have four common shares for every one common share held at the close of business on the record date and the total capitalization of the Company's common stock will increase from 21,160,000 shares outstanding to 84,640,000 shares outstanding.

About MedEx, Inc.

MedEx, Inc. is a medical acquisition company specializing in the acquisition of medical supply companies, medical technology companies, and assisted living and care facilities worldwide.

Safe Harbor Statement:

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or planned, "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.